Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Immunization rates hit record high in poor countries

29.01.2007
GAVI immunization programs in 2006 prevented 600,000 future deaths, new data shows -- GAVI to devote US $500 million to strengthen health systems in developing countries

New data from the World Health Organization (WHO) show that the GAVI Alliance, a groundbreaking global initiative to increase access to children’s vaccines, has brought immunisation rates to record highs in poor countries.

The WHO data, released today at the World Economic Forum’s annual meeting, project that since 2000, GAVI-funded immunisation programs in developing countries have prevented approximately 2.3 million future deaths, and that immunisations in 2006 alone prevented 600,000 future deaths.

Bill and Melinda Gates, co-chairs of the Bill & Melinda Gates Foundation, called the new data a highly encouraging sign of progress in global health. The Gates Foundation has committed a total of US$1.5 billion to support GAVI to date. GAVI has also received funding from 17 donor governments, including Germany, which recently committed €8 million (US$10.4 million).

"GAVI and its partners are leading a major turnaround in children’s health," said Melinda Gates. "When GAVI was founded, immunisation rates in poor countries were on the decline. Today, they are at an all-time high."

Since its inception in 2000, GAVI has committed US$2.6 billion to support national immunisation programs in more than 70 developing countries. According to the WHO projections released today, as a result of GAVI funding:

- 28 million more children have been protected against diphtheria, tetanus, and pertussis, helping to increase overall immunisation rates for these diseases from 63 percent in 1999 to 77 percent in 2006.

- 138 million more children have received new and under-used vaccines, such as those for hepatitis B, Hib, and yellow fever, helping to greatly increase immunisation coverage for these diseases. For example, the number of developing countries providing hepatitis B vaccine rose from 15 in 1999 to 61 in 2006.

"GAVI has demonstrated that with the right resources and leadership, it is possible to make dramatic health gains in poor countries," said Bill Gates. "We need to build on this success. No child should be denied access to lifesaving immunisations."

Despite GAVI’s progress, in 2005, an estimated 28 million children in developing countries were not immunised, and 2.5 million children died of vaccine-preventable diseases. To close this gap, WHO and UNICEF estimate that an additional US$10-15 billion will be needed for immunisation programs over the next decade. More funding will be needed to introduce vaccines that are currently in the development pipeline.

GAVI Commits US$500 Million to Strengthen Health Systems

In an effort to further increase global immunisation coverage, GAVI also announced today that it will invest US$500 million over five years to strengthen basic health systems in developing countries.

Weak health care infrastructure is often the main barrier to providing immunisations to children in developing countries, particularly in the poorest and most remote communities.

The new GAVI funding will provide flexible grants to developing countries for activities such as:

- Recruiting and training health care workers

- Building and strengthening systems to distribute vaccines and drugs

- Transporting health care workers and equipment
- Purchasing basic medical supplies, such as antibiotics and clean childbirth kits

"This is an exciting new direction for us," said Julian Lob-Levyt, Executive Secretary of GAVI. "Developing country leaders are telling us that in order for immunisation programs to be sustained, they need greater support for basic health infrastructure."

The first round of GAVI grants for strengthening health systems will be announced in February.

Jean-Pierre Le Calvez | EurekAlert!
Further information:
http://www.gavialliance.org

More articles from Studies and Analyses:

nachricht Multi-year study finds 'hotspots' of ammonia over world's major agricultural areas
17.03.2017 | University of Maryland

nachricht Diabetes Drug May Improve Bone Fat-induced Defects of Fracture Healing
17.03.2017 | Deutsches Institut für Ernährungsforschung Potsdam-Rehbrücke

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Argon is not the 'dope' for metallic hydrogen

24.03.2017 | Materials Sciences

Astronomers find unexpected, dust-obscured star formation in distant galaxy

24.03.2017 | Physics and Astronomy

Gravitational wave kicks monster black hole out of galactic core

24.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>